COSM (Cosmos Health) Risk Assessment


COSM Cosmos Health Inc COSM
29 GF Score
Price $0.21
GF Value $0.36
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Cosmos Health Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Cosmos Health is: High Risk: High uncertainty.

Cosmos Health  (NAS:COSM) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Cosmos Health Risk Assessment Related Terms

COSM vs HKPD, SNYR, YI: Risk Assessment Comparison

For the Medical Distribution subindustry, Cosmos Health's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cosmos Health Risk Assessment vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cosmos Health's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Cosmos Health's Risk Assessment falls into.


COSM
29GF Score
Cosmos Health Inc COSM
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cosmos Health (COSM) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued. The current stock price of $0.21 is trading 40.3% below its estimated GF Value™ of $0.36. GuruFocus considers Cosmos Health to be Possible Value Trap.

Key valuation signals for COSM:

  • Risk Assessment:
  • GF Value™: $0.36 vs. price of $0.21 (40.3% below fair value)
  • GF Score™: 29/100 with 6 warning signs

No single metric tells the full story. See the COSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosmos Health Business Description

Other Exchanges V67A:Germany
Address 5 Agiou Georgiou Street, Pilea, Thessaloniki, GRC, 55438
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
29GF Score

Get the complete analysis for COSM

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.21
Price
$0.36
GF Value